Ekincioğlu Aygin Bayraktar, Demirkan Kutay
Department of Clinical Pharmacy, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey.
Ulus Cerrahi Derg. 2013 Nov 14;29(4):177-86. doi: 10.5152/UCD.2013.112013. eCollection 2013.
A drug's plasma level, pharmacological effects or side effects, elimination, physicochemical properties or stability could be changed by interactions of drug-drug or drug-nutrition products in patients who receive enteral or parenteral nutritional support. As a result, patients might experience ineffective outcomes or unexpected effects of therapy (such as drug toxicity, embolism). Stability or incompatibility problems between parenteral nutrition admixtures and drugs might lead to alterations in expected therapeutic responses from drug and/or parenteral nutrition, occlusion in venous catheter or symptoms or mortality due to infusion of composed particles. Compatibilities between parenteral nutrition and drugs are not always guaranteed in clinical practice. Although the list of compatibility or incompatibilities of drugs are published for the use of clinicians in their practices, factors such as composition of parenteral nutrition admixture, drug concentration, contact time in catheter, temperature of the environment and exposure to light could change the status of compatibilities between drugs and nutrition admixtures. There could be substantial clinical changes occurring in the patient's nutritional status and pharmacological effects of drugs due to interactions between enteral nutrition and drugs. Drug toxicity and ineffective nutritional support might occur as a result of those predictable interactions. Although administration of drugs via feeding tube is a complex and problematic route for drug usage, it is possible to minimise the risk of tube occlusion, decreased effects of drug and drug toxicity by using an appropriate technique. Therefore, it is important to consider pharmacological dosage forms of drugs while administering drugs via a feeding tube. In conclusion, since the pharmacists are well-experienced and more knowledgeable professionals in drugs and drug usage compared to other healthcare providers, it is suggested that provision of information and drug counselling by pharmacists in terms of detection and prevention of problems (such as interactions, stability, incompatibility) related with enteral/parenteral nutrition and drugs are invaluable in clinical practice.
在接受肠内或肠外营养支持的患者中,药物与药物或药物与营养产品之间的相互作用可能会改变药物的血浆水平、药理作用或副作用、消除、理化性质或稳定性。因此,患者可能会出现治疗效果不佳或意外效应(如药物毒性、栓塞)。肠外营养混合液与药物之间的稳定性或不相容性问题可能会导致药物和/或肠外营养的预期治疗反应发生改变、静脉导管堵塞或因输注混合颗粒而出现症状或死亡。在临床实践中,肠外营养与药物之间的相容性并非总能得到保证。尽管已公布药物相容性或不相容性列表供临床医生在实践中使用,但诸如肠外营养混合液的成分、药物浓度、在导管中的接触时间、环境温度和光照等因素可能会改变药物与营养混合液之间的相容性状态。由于肠内营养与药物之间的相互作用,患者的营养状况和药物药理作用可能会发生重大临床变化。这些可预测的相互作用可能会导致药物毒性和营养支持效果不佳。尽管通过饲管给药是一种复杂且存在问题的用药途径,但通过采用适当技术,可以将饲管堵塞、药物效果降低和药物毒性的风险降至最低。因此,通过饲管给药时考虑药物的剂型很重要。总之,由于与其他医疗保健提供者相比,药剂师在药物及用药方面经验更丰富、知识更渊博,建议药剂师在检测和预防与肠内/肠外营养和药物相关的问题(如相互作用、稳定性、不相容性)方面提供信息和药物咨询,这在临床实践中非常宝贵。